Developing and using 3D hologram technology (ELVIS) to guide physicians during cardiac ablation procedures.
Improving addiction outcomes through the CAPA Collaboration (a community-university partnership) and the development of a clinical dashboard to guide and track recovery.
Creating technology that uses physiological measures to help adolescents prevent their own worsening suicidality and suicide attempts.
Reducing risk factors for Type 2 diabetes through a collective impact approach.
Identifying a better antiseptic for use in skin cleansing before cesarean section, reducing the risk of surgical-site infections.
Studying the uptake of PrEP in high-risk populations, leading to an expansion of services including a new clinic.
Exploring the translating mechanisms for a genetic neurodegenerative disease to identify patient-based therapies and actionable targets.
Increasing accessibility and uptake of long-term, reversible contraception for almost 10,000 women, reducing teen pregnancy and abortion rates in the St. Louis Missouri area.
Exploring promising, noninvasive screening methods for the early detection of kidney cancer, including urine biomarkers.
Developing new preliminary diagnostic procedures for early detection of the rapidly progressive neurodegenerative disease through diffusion tensor imaging.